Provided by Tiger Trade Technology Pte. Ltd.

Cardiol Therapeutics Inc

1.01
0.0000
Volume:342.50K
Turnover:345.61K
Market Cap:101.00M
PE:-3.34
High:1.03
Open:1.01
Low:1.00
Close:1.01
52wk High:1.59
52wk Low:0.7709
Shares:100.00M
Float Shares:91.98M
Volume Ratio:1.09
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3023
EPS(LYR):-0.3562
ROE:-347.98%
ROA:-148.83%
PB:14.48
PE(LYR):-2.84

Loading ...

Company Profile

Company Name:
Cardiol Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
18
Office Location:
2265 Upper Middle Road East,Suite 602,Oakville,Ontario,Canada
Zip Code:
L6H 0G5
Fax:
905 481 2394
Introduction:
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.